New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Mark Cuban: A Master Disrupter for American Health...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
High-speed imaging tracks live brain cell activity...
World is falling behind on UN's child mortality Sustainable ...
April 16,2026
Health literacy initiative improves discharge education, rea...
April 15,2026
Constipation is common, but with simple changes, you can man...
April 14,2026
Children and teenagers more open to meat free diets—but stru...
April 13,2026
3D-printed ATLAS platform helps model cancer cell clusters b...
April 12,2026
3 million-cell map shows menopause reshapes breast tissue, p...
April 11,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Today's News
Why is Alzheimer’s disease so difficult to treat? ...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Study to examine impact of therapy animals on children with cancer

Study to examine impact of therapy animals on children with cancer

by Vanderbilt University Medical CenterMary Jo Gilmer with therapy dog Annabelle at Monroe Carell Jr. Children's Hospital at Vanderbilt. Credit: Susan Urmy/VanderbiltThe sight of a dog in a t
Oncology May 25,2024
Study to examine impact of therapy animals on children with cancer

Study to examine impact of therapy animals on children with cancer

by Vanderbilt University Medical CenterMary Jo Gilmer with therapy dog Annabelle at Monroe Carell Jr. Children's Hospital at Vanderbilt. Credit: Susan Urmy/VanderbiltThe sight of a dog in a t
Oncology May 25,2024
Drug yields high response rates for lung cancer patients with harsh mutation

Drug yields high response rates for lung cancer patients with harsh mutation

by University of Texas M. D. Anderson Cancer CenterCredit: University of Texas M. D. Anderson Cancer CenterA targeted therapy resurrected by the Moon Shots Program at The University of Texas MD A
Oncology May 25,2024
Drug yields high response rates for lung cancer patients with harsh mutation

Drug yields high response rates for lung cancer patients with harsh mutation

by University of Texas M. D. Anderson Cancer CenterCredit: University of Texas M. D. Anderson Cancer CenterA targeted therapy resurrected by the Moon Shots Program at The University of Texas MD A
Oncology May 25,2024
Drug mechanism opens door for new anti-cancer immunotherapies

Drug mechanism opens door for new anti-cancer immunotherapies

by King's College LondonCredit: CC0 Public DomainResearchers have revealed a new mechanism of targeted drug treatment used against chronic lymphocytic leukemia, through the promotion of immun
Oncology May 25,2024
Drug mechanism opens door for new anti-cancer immunotherapies

Drug mechanism opens door for new anti-cancer immunotherapies

by King's College LondonCredit: CC0 Public DomainResearchers have revealed a new mechanism of targeted drug treatment used against chronic lymphocytic leukemia, through the promotion of immun
Oncology May 25,2024
Drug shows promise as immune therapy for cancer

Drug shows promise as immune therapy for cancer

by Ziba Kashef,Yale UniversityNew Yale-led research may offer novel immunotherapies for skin, colon, breast, pancreatic and other cancers. Credit: stock.adobe.comA therapy developed by Yale rese
Oncology May 25,2024
Drug shows promise as immune therapy for cancer

Drug shows promise as immune therapy for cancer

by Ziba Kashef,Yale UniversityNew Yale-led research may offer novel immunotherapies for skin, colon, breast, pancreatic and other cancers. Credit: stock.adobe.comA therapy developed by Yale rese
Oncology May 25,2024
Eye-safe laser technology to diagnose traumatic brain injury

Eye-safe laser technology to diagnose traumatic brain injury

by University of BirminghamThe engineered EyeD overview. (A) Convergence of a collimated beam entering the eye onto the retina (left) and the compound lens effect (right) resulting from the intro
Neurology May 25,2024
Eye-safe laser technology to diagnose traumatic brain injury

Eye-safe laser technology to diagnose traumatic brain injury

by University of BirminghamThe engineered EyeD overview. (A) Convergence of a collimated beam entering the eye onto the retina (left) and the compound lens effect (right) resulting from the intro
Neurology May 25,2024
Drug makes tumors more susceptible to chemo

Drug makes tumors more susceptible to chemo

by Massachusetts Institute of TechnologyStructure of the complex containing Rev1 and JH-RE-06. The two copies of the Rev1 protein are shown in dark and light blue, while the small molecule JH-RE-
Oncology May 25,2024
Drug makes tumors more susceptible to chemo

Drug makes tumors more susceptible to chemo

by Massachusetts Institute of TechnologyStructure of the complex containing Rev1 and JH-RE-06. The two copies of the Rev1 protein are shown in dark and light blue, while the small molecule JH-RE-
Oncology May 25,2024
Pet ownership may contribute to health care barriers for people with HIV

Pet ownership may contribute to health care barriers for people with HIV

by University of FloridaCredit: Pixabay/CC0 Public DomainPeople living with HIV may face hard choices when balancing their own health needs with caring for a pet, a study led by a University of F
Public Health & Prevention May 25,2024
Pet ownership may contribute to health care barriers for people with HIV

Pet ownership may contribute to health care barriers for people with HIV

by University of FloridaCredit: Pixabay/CC0 Public DomainPeople living with HIV may face hard choices when balancing their own health needs with caring for a pet, a study led by a University of F
Public Health & Prevention May 25,2024
Study supports PSA screening for male BRCA2 carrier

Study supports PSA screening for male BRCA2 carrier

(HealthDay)—Systematic prostate-specific antigen (PSA) screening is advised for men who are carriers of theBRCA2mutation, which is associated with a higher incidence of prostate cancer, yo
Oncology May 25,2024
Study supports PSA screening for male BRCA2 carrier

Study supports PSA screening for male BRCA2 carrier

(HealthDay)—Systematic prostate-specific antigen (PSA) screening is advised for men who are carriers of theBRCA2mutation, which is associated with a higher incidence of prostate cancer, yo
Oncology May 25,2024
Doctors are being sexually harassed at work—this needs to stop

Doctors are being sexually harassed at work—this needs to stop

by Louise Stone,The ConversationCredit: Unsplash/CC0 Public DomainDominique Leewas training in radiation oncology when she was invited to join her supervisor to discuss a training opportun
Oncology May 25,2024
Doctors are being sexually harassed at work—this needs to stop

Doctors are being sexually harassed at work—this needs to stop

by Louise Stone,The ConversationCredit: Unsplash/CC0 Public DomainDominique Leewas training in radiation oncology when she was invited to join her supervisor to discuss a training opportun
Oncology May 25,2024
Study: Fat cells play key role in dangerous transformation of melanoma

Study: Fat cells play key role in dangerous transformation of melanoma

by Tel Aviv UniversityNano-vaccine mechanism of action: following injection, the nano-vaccine internalizes into immune cells, leading to activation of T cells to recognize and attack melanoma. Cr
Oncology May 25,2024
Study: Fat cells play key role in dangerous transformation of melanoma

Study: Fat cells play key role in dangerous transformation of melanoma

by Tel Aviv UniversityNano-vaccine mechanism of action: following injection, the nano-vaccine internalizes into immune cells, leading to activation of T cells to recognize and attack melanoma. Cr
Oncology May 25,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu... ... Eye Infections (Updated) | Clinical Medicine ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com